JPMorgan initiates JMDC stock with Overweight rating on healthcare data growth

Published 07/07/2025, 15:32
JPMorgan initiates JMDC stock with Overweight rating on healthcare data growth

Investing.com - JPMorgan has initiated coverage on JMDC Inc (TYO:4483) with an Overweight rating and a price target of JPY5,000.00 through December 2026.

The investment bank expects JMDC’s healthcare Big Data segment to continue its strong performance, forecasting sales growth of at least 20% year-over-year and an operating profit compound annual growth rate of approximately 25% from fiscal year 2024 through 2029.

JPMorgan notes that JMDC’s share price has been declining due to adjustments in sales expectations for life insurance and weak sales in the pharmaceutical medical affairs division within its core healthcare data business.

Despite these challenges, the firm highlights that sales for JMDC’s pharmaceutical marketing division are expanding rapidly, potentially offsetting weaknesses in other areas.

While earnings consensus and valuations have recently trended upward, JPMorgan sees further upside potential for JMDC, citing structural tailwinds from shifts in the pharmaceutical market over the longer term.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.